scholarly article | Q13442814 |
P50 | author | Sanjiv A Luther | Q51797070 |
P2093 | author name string | J G Cyster | |
W Bai | |||
T Lopez | |||
D Hanahan | |||
P2860 | cites work | LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator | Q24308657 |
B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 | Q24309316 | ||
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 | Q28263524 | ||
A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin | Q28507630 | ||
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs | Q28594485 | ||
Development and maturation of secondary lymphoid tissues. | Q33652498 | ||
Chemokines and cell migration in secondary lymphoid organs | Q33807114 | ||
Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. | Q33854381 | ||
The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes | Q33877237 | ||
Long-term impaired neutrophil migration in mice overexpressing human interleukin-8 | Q34186214 | ||
Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells | Q34325984 | ||
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen | Q34488105 | ||
Chronic inflammation caused by lymphotoxin is lymphoid neogenesis | Q36366337 | ||
In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines | Q36375434 | ||
B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. | Q36400576 | ||
The sequential role of lymphotoxin and B cells in the development of splenic follicles. | Q36400592 | ||
BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma | Q36762885 | ||
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. | Q41423746 | ||
Novel lymphocyte-specific CC chemokines and their receptors. | Q41640121 | ||
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization | Q42064511 | ||
Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs | Q42196937 | ||
Keratinocyte-Derived Monocyte Chemoattractant Protein 1 (MCP-1): Analysis in a Transgenic Model Demonstrates MCP-1 Can Recruit Dendritic and Langerhans Cells to Skin | Q42479824 | ||
Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells | Q42753323 | ||
Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice | Q43831668 | ||
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene | Q46098688 | ||
Lymph node genesis is induced by signaling through the lymphotoxin beta receptor | Q47713223 | ||
Reticular cells in peripheral lymphoid tissues express the phosphatidylinositol-linked BP-3 antigen | Q52237971 | ||
Turning off follicular dendritic cells | Q59068710 | ||
Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells | Q68111034 | ||
Organogenic role of B lymphocytes in mucosal immunity | Q73232930 | ||
Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells | Q73838320 | ||
IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches | Q77756301 | ||
Peyer's patch organogenesis as a programmed inflammation: a hypothetical model | Q77903801 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 471-481 | |
P577 | publication date | 2000-05-01 | |
P1433 | published in | Immunity | Q6005457 |
P1476 | title | BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis | |
P478 | volume | 12 |
Q24793642 | A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells |
Q41838799 | A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis |
Q28142202 | A chemokine-driven positive feedback loop organizes lymphoid follicles |
Q35108664 | A critical role for dendritic cells in the formation of lymphatic vessels within tertiary lymphoid structures |
Q34712801 | A lympho-follicular microenvironment is required for pathological prion protein deposition in chronically inflamed tissues from scrapie-affected sheep |
Q35205183 | A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation |
Q34550498 | ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis. |
Q24794011 | Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome |
Q38242815 | Adventitial inflammation and its interaction with intimal atherosclerotic lesions |
Q81402177 | Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis |
Q47603503 | Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection |
Q38525103 | Antibody-independent functions of B cells: a focus on cytokines |
Q84564792 | Antigen-dependent rescue of nose-associated lymphoid tissue (NALT) development independent of LTbetaR and CXCR5 signaling |
Q33577355 | Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis |
Q37761494 | Artificial engineering of secondary lymphoid organs. |
Q40233488 | Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice |
Q30475578 | Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans |
Q34163322 | Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study |
Q34296482 | Attractions and migrations of lymphoid cells in the organization of humoral immune responses |
Q33601679 | Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future |
Q93047673 | Autoimmune-Mediated Retinopathy in CXCR5-Deficient Mice as the Result of Age-Related Macular Degeneration Associated Proteins Accumulation |
Q90506533 | B cell and B cell-related pathways for novel cancer treatments |
Q24669900 | B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue |
Q48507544 | B cells in the pathogenesis of primary Sjögren syndrome |
Q37995310 | B effector cells in rheumatoid arthritis and experimental arthritis |
Q44779139 | B lymphocytes and cancer: a love-hate relationship |
Q33345109 | B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system? |
Q38124120 | B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies. |
Q57041869 | B-cell subsets: cellular interactions and relevance in multiple sclerosis |
Q41368509 | Balance between Estrogens and Proinflammatory Cytokines Regulates Chemokine Production Involved in Thymic Germinal Center Formation |
Q35884238 | Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation |
Q37189681 | Bimodal Expansion of the Lymphatic Vessels Is Regulated by the Sequential Expression of IL-7 and Lymphotoxin α1β2 in Newly Formed Tertiary Lymphoid Structures |
Q37207114 | Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice |
Q36095617 | CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. |
Q61805076 | CD11c Cells Are Gatekeepers for Lymphocyte Trafficking to Infiltrated Islets During Type 1 Diabetes |
Q36368291 | CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function |
Q30480094 | CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells |
Q40550187 | CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome |
Q37299504 | CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice |
Q35869068 | CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract |
Q35001976 | CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles |
Q37238275 | CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis |
Q28217241 | CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity |
Q52654842 | CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome. |
Q100762031 | CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia |
Q38751056 | CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer |
Q38071420 | Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus. |
Q27012852 | Characteristics of tertiary lymphoid structures in primary cancers |
Q37795157 | Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting |
Q34296506 | Chemokines in immunity |
Q34167947 | Chemokines in lymphopoiesis and lymphoid organ development |
Q34139595 | Chemokines: immunology's high impact factors |
Q36488894 | Clinical utilization of chemokines to combat cancer: the double-edged sword |
Q35084291 | Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development |
Q38025388 | Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis. |
Q34418024 | Dendritic cells in autoimmune diseases |
Q33816393 | Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues |
Q35098101 | Detection of a sulfotransferase (HEC-GlcNAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates: relationship to the MECA-79 epitope. |
Q47357498 | Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. |
Q78651212 | Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches |
Q36991047 | Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues |
Q49906688 | Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing |
Q35216954 | Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting |
Q44158648 | Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues |
Q38190588 | EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjögren's syndrome. |
Q35119934 | Ectopic Germinal Center Formation in Rheumatoid Synovitis |
Q36370988 | Ectopic LTαβ Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase |
Q28077990 | Ectopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur? |
Q26778348 | Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues |
Q35953359 | Ectopic lymphoid neogenesis in psoriatic arthritis |
Q35834582 | Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis |
Q34363840 | Ectopic lymphoid organogenesis: a fast track for autoimmunity |
Q37075235 | Ectopic lymphoid tissues and local immunity |
Q38221815 | Ectopic lymphoid-like structures in infection, cancer and autoimmunity |
Q38091729 | Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease |
Q92039325 | Epigenetically quantified immune cells in salivary glands of Sjögren's syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopathology |
Q33920116 | Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations |
Q34225157 | Expression profiling in knockout mice: lymphotoxin versus tumor necrosis factor in the maintenance of splenic microarchitecture |
Q34198891 | Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. |
Q90702784 | Functional heterogeneity of resident fibroblasts in the kidney |
Q53535370 | Gene expression profiles at different stages of collagen-induced arthritis. |
Q40487229 | Generation of a synthetic lymphoid tissue-like organoid in mice |
Q39755242 | Helicobacter-induced chronic active lymphoid aggregates have characteristics of tertiary lymphoid tissue |
Q39143550 | High Endothelial Venules and Other Blood Vessels: Critical Regulators of Lymphoid Organ Development and Function |
Q44667648 | Histochemical analysis of lymphatic endothelial cells in the pancreas of non-obese diabetic mice |
Q37922092 | Homeostatic chemokine receptors and organ-specific metastasis |
Q24806177 | Homing chemokines in rheumatoid arthritis. |
Q47730836 | IL-1 and TNF-alpha play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus-induced experimental brain abscess |
Q39021612 | IL-17 initiates tertiary lymphoid organ formation |
Q36055624 | IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs |
Q99200542 | Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration |
Q47195254 | Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity |
Q93065024 | Immunology of the ageing kidney |
Q33565121 | In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity |
Q39677907 | Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection |
Q26742160 | Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung |
Q34586903 | Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. |
Q36253046 | Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice |
Q33464362 | Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals |
Q34568588 | Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. |
Q34731135 | Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response |
Q36180696 | Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. |
Q36633456 | Keystones in lymph node development |
Q81421972 | Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis |
Q36441358 | Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection |
Q35044757 | Lymphocyte traffic control by chemokines: follicular B helper T cells |
Q37186200 | Lymphoid chemokines in chronic neuroinflammation |
Q35788605 | Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status |
Q36405080 | Lymphoid neogenesis in chronic inflammatory diseases. |
Q31156611 | Lymphoid organ development and cell migration |
Q35691047 | Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. |
Q33399367 | Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice |
Q39245218 | Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy. |
Q89506054 | Lymphotoxin targeted to salivary and lacrimal glands induces tertiary lymphoid organs and cervical lymphadenopathy and reduces tear production |
Q35219029 | Lymphotoxin/light, lymphoid microenvironments and autoimmune disease |
Q44130049 | Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. |
Q91938983 | M Cells: Intelligent Engineering of Mucosal Immune Surveillance |
Q54541923 | M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. |
Q34516535 | Maintenance and loss of self-tolerance in B cells |
Q34815328 | Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway |
Q35165545 | Michael Mason prize essay 2003. Why do leucocytes accumulate within chronically inflamed joints? |
Q35842700 | Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia |
Q42076869 | Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. |
Q24685626 | Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules |
Q24300326 | Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis |
Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
Q37737987 | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease |
Q34731168 | Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity |
Q36946564 | Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis |
Q42944282 | On the role of the innate immunity in autoimmune disease |
Q35096187 | Organogenesis of lymphoid tissues |
Q24322068 | Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia |
Q28585776 | Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development |
Q35772863 | Pathogenic roles of B cells in human autoimmunity; insights from the clinic |
Q43143999 | Peanuts can contribute to anaphylactic shock by activating complement. |
Q90479784 | Phosphatase PTPN22 Regulates Dendritic Cell Homeostasis and cDC2 Dependent T Cell Responses |
Q36370525 | Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. |
Q37591982 | Progressive multiple sclerosis. |
Q35973395 | Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza |
Q33772300 | Regulated Production of CXCL13 within the Central Nervous System |
Q37784683 | Regulation of inducible BALT formation and contribution to immunity and pathology. |
Q47165275 | Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation |
Q36369174 | Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor |
Q52544618 | Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. |
Q49123591 | Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease |
Q57825775 | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis |
Q89278062 | Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer |
Q37576573 | Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues |
Q38204888 | Saliva-microbe interactions and salivary gland dysfunction. |
Q34373668 | Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia |
Q33766434 | Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels |
Q89669149 | Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome |
Q56603390 | Shaping Up Adaptive Immunity: The Impact of CCR7 and CXCR5 on Lymphocyte Trafficking |
Q36369671 | Splenic T zone development is B cell dependent |
Q47110972 | Spoiling for a Fight: B Lymphocytes As Initiator and Effector Populations within Tertiary Lymphoid Organs in Autoimmunity and Transplantation. |
Q28068106 | Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation |
Q27693895 | Stromal cell regulation of homeostatic and inflammatory lymphoid organogenesis |
Q60810884 | Systematic microanatomical analysis of CXCL13 and CCL21in situ production and progressive lymphoid organization in rheumatoid synovitis |
Q58712847 | T Cells That Help B Cells in Chronically Inflamed Tissues |
Q34858190 | T-cell activation: a multidimensional signaling network. |
Q30743828 | TNF ligands and receptors in autoimmunity: an update |
Q35036338 | TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines. |
Q34690481 | TNFα-dependent development of lymphoid tissue in the absence of RORγt⁺ lymphoid tissue inducer cells |
Q36551188 | Targeting CXCL13 During Neuroinflammation |
Q47194123 | Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease? |
Q38012568 | Tertiary lymphoid organs in infection and autoimmunity |
Q36715727 | Tertiary lymphoid organs in lymphatic malformations |
Q58424599 | The Development of Primary and Secondary Lymphoid Tissues in the Nurse SharkGinglymostoma cirratum: B-Cell Zones Precede Dendritic Cell Immigration and T-Cell Zone Formation During Ontogeny of the Spleen |
Q27025082 | The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity |
Q28203717 | The TNF and TNF receptor superfamilies: integrating mammalian biology |
Q33986306 | The central role of antigen presentation in islets of Langerhans in autoimmune diabetes |
Q24291904 | The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells |
Q42202704 | The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation |
Q43408798 | The chemokine-binding protein M3 as a tool to understand the chemokine network in vivo |
Q34191942 | The development of inducible bronchus-associated lymphoid tissue depends on IL-17. |
Q34573771 | The enemy within: keeping self-reactive T cells at bay in the periphery |
Q98205361 | The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy |
Q35216957 | The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity |
Q35104199 | The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system |
Q35005856 | The role of CD45+CD4+CD3- cells in lymphoid organ development |
Q36992526 | The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis |
Q38118108 | The role of viruses in autoreactive B cell activation within tertiary lymphoid structures in autoimmune diseases |
Q37770209 | The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development |
Q26799123 | Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment |
Q44285977 | Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease |
Q42852796 | Transplantation of embryonic spleen tissue reveals a role for adult non-lymphoid cells in initiating lymphoid tissue organization. |
Q40996042 | Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering |
Q35088161 | Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane) |
Q34083294 | Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. |
Q51617066 | Vagal innervation is required for the formation of tertiary lymphoid tissue in colitis. |
Search more.